The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Record day for Covid-19 vaccinations in UK as over 700,000 get jab

Sun, 21st Mar 2021 09:11

(Alliance News) - A record number of people received their Covid-19 vaccine on Friday, with 711,156 doses given to the UK public.

More than half of the UK's adult population – some 26,853,407 people aged 18 and over – have now received their first jab, Government data up to March 19 suggests.

Health Secretary Matt Hancock hailed the milestone as a "phenomenal achievement".

The Department of Health & Social Care said it remains "on track" to offer the vaccine to all over-50s by April 15.

It comes as countries across Europe have had to impose tougher restrictions amid a rise in Covid-19 cases, with UK scientists warning overseas holidays this summer will be "extremely unlikely".

Prime Minister Boris Johnson was among those to receive his first dose on Friday when he was given the Oxford University and AstraZeneca PLC vaccine at St Thomas' Hospital in central London.

Friday's record daily total includes both first and second doses across the UK.

Of those, 636,219 were given in England – the highest daily amount since the NHS vaccination programme began, NHS England said.

Hancock said: "Vaccinating over half of all adults is a phenomenal achievement and is testament to the mammoth efforts of the NHS, GPs, volunteers, local authorities and civil servants in every corner of the UK.

"During April, we will continue to vaccinate those most at risk and around 12 million people will receive their second doses as well.

"It is absolutely crucial people come forward as soon as they are eligible. When you get the call, get the jab, because the more people who are vaccinated the safer we will all be."

Some 2,132,551 people in the UK – around 4% of all adults – have been given their second dose of the vaccine, while almost 95% of people aged 60 and over have received their first jab, the DHSC said.

Meanwhile, experts have warned there could be a third wave of Covid-19 infections in the UK and advised people not to consider overseas holidays when restrictions ease later this year.

Mike Tildesley, a member of the Spi-M modelling group which advises the government, said there was a danger that new variants could jeopardise the vaccination programme later in the year.

The infectious disease expert Tildesley told BBC Radio 4's Today programme: "I think that international travel this summer is, for the average holidaymaker, sadly I think, extremely unlikely.

"I think we are running a real risk if we do start to have lots of people going overseas in July and August because of the potential for bringing more of these new variants back into the country.

"What is really dangerous is if we jeopardise our vaccination campaign by having these variants where the vaccines don't work as effectively spreading more rapidly."

Government sources said the UK needs to be wary of what is happening in Europe "because in the past that has led to a rise here a few weeks later", although how things will pan out is uncertain.

European countries are seeing pockets of the South African variant, with studies suggesting vaccines work less well against this strain of the virus.

In the UK, hospital admissions and deaths are still coming down due to the effect of vaccines, but there are worries that cases could rise quickly once restrictions are eased.

Andrew Hayward, a member of the Scientific Advisory Group for Emergencies, said although another wave was "likely" in the UK, the impact could be less deadly than previous ones.

He told Times Radio: "I think another wave is possible. Likely, even.

"I guess the difference is that another wave will cause substantially fewer deaths and hospitalisations because of high levels of vaccination across the sorts of people who would have ended up in hospital or unfortunately dying if they haven't been vaccinated.

"So the consequences of another wave are less. I think the challenge is of course we don't know exactly how much less."

Experts believe there will be an increasing "disconnect" between cases and hospital admissions and deaths going forward, as vaccines work to keep people from dying.

Regarding foreign holidays this summer, UK government scientists say it is still unclear what will happen, but the risk of importing cases and variants comes from countries with a higher prevalence than the UK.

In Europe, the French government announced that new lockdown restrictions would be imposed on Paris from midnight on Friday due to an increase in cases.

Chancellor Angela Merkel said Germany may need to apply an "emergency break" on relaxing restrictions amid a rise in infections.

Poland began a new three-week lockdown on Saturday, with shops, hotels, cultural and sporting facilities closed.

Countries including France, Germany and Italy have begun restarting their vaccine programmes with the AstraZeneca jab – reversing earlier decisions to suspend them over blood clot concerns.

The rollout of the AstraZeneca coronavirus vaccine resumed in Ireland on Saturday.

By Luke Powell and Jane Kirby, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.